The RESPONDER trial: a feasibility study of an early intervention model deploying community first responders to administer intranasal naloxone in suspected opioid overdoses in Skåne, Sweden.  Rehn J, Andréll C, Hansson J, Troberg K, Isendahl P…

Use of naloxone by EMS for opioid-associated out-of-hospital cardiac arrest and associated patient-centered outcomes: A systematic review.  Siddiqui H, Brouillette K, Walsh C, Cheskes S, Drennan IR, Keown-Stoneman CDG, Lin S, Mohindra R. …

Neue Substitutionsrichtlinie: BÄK nimmt nasales Take-home-Naloxon auf Die Bundesärztekammer hat ihre Richtlinie zur Durchführung der substitutionsgestützten Behandlung Opioidabhängiger/Opioid-Agonisten-Therapie (OAT) aktualisiert. Die übe…

Leveraging near-peer teaching: the impact of cognitive and social congruence on naloxone training.  Polcyn J, VanBrackle R Jr, Zink N, Covington K, Heboyan V, Rockich-Winston N.  Med Educ Online. 2026 Dec 31;31(1):2676337. doi: 10.1080/1…

Trends and Outcomes of Naloxone Use for Iatrogenic Opioid Overdose in Patients on General Wards in a Swiss Hospital: A Ten-Year Retrospective Case Series Analysis.  Würsten M, Meyer-Massetti C, Leuppi-Taegtmeyer A, Goetschi AN.  Drug Hea…

Beyond access: improving real-world naloxone use to address the opioid overdose epidemic.  Neuenschwander J, Wilkerson RG, Weiner SG.  Int J Emerg Med. 2026 Jun 4;19(1):152. doi: 10.1186/s12245-026-01261-7. PMID: 42243669; PMCID: PMC1323…